Bain Capital Life Sciences Investors, LLC Long-Term Concentrated

Location: Boston, MA

CIK: 0001703031 · Show all filings

Period: Q4 2021 (← Previous) (Next →)

Filing Date: Feb 14, 2022

Total Value: $1.261B (100.0% shares, 0.0% debt)

Holdings (34)

— SPRINGWORKS THERAPEUTICS INC 23.7%

Value $299M Shares 4,831,307 Est. Cost $21.68 Unrealized —

— DYNAVAX TECHNOLOGIES CORP 9.4%

Value $118M Shares 8,415,000 Est. Cost $9.83 Unrealized —

RPID RAPID MICRO BIOSYSTEMS INC 7.1%

Value $89.74M Shares 8,434,560 Est. Cost $20.66 Unrealized -24.4%

ARQT ARCUTIS BIOTHERAPEUTICS INC 6.5%

Value $82.53M Shares 3,979,292 Est. Cost $26.87 Unrealized -25.9%

— EQRX INC 5.4%

Value $68.22M Shares 10,003,573 Est. Cost $6.82 Unrealized —

NUVL NUVALENT INC 5.2%

Value $65.27M Shares 3,428,014 Est. Cost $29.01 Unrealized -23.2%

CRNX CRINETICS PHARMACEUTICALS IN 4.6%

Value $57.66M Shares 2,029,701 Est. Cost $18.52 Unrealized +33.1%

CCCC C4 THERAPEUTICS INC 4.2%

Value $52.88M Shares 1,642,210 Est. Cost $29.00 Unrealized +36.4%

PHVS PHARVARIS N V 3.6%

Value $45.77M Shares 3,180,601 Est. Cost $31.46 Unrealized -50.3%

XLO XILIO THERAPEUTICS INC 3.6%

Value $44.89M Shares 2,805,413 Est. Cost $17.03 Unrealized 0.0%

ANNX ANNEXON INC 3.0%

Value $37.25M Shares 3,241,628 Est. Cost $23.46 Unrealized -31.1%

NRIX NURIX THERAPEUTICS INC 2.9%

Value $37.18M Shares 1,284,313 Est. Cost $25.20 Unrealized +20.3%

— MERSANA THERAPEUTICS INC 2.7%

Value $33.5M Shares 5,385,667 Est. Cost $17.67 Unrealized —

— APTINYX INC 1.9%

Value $23.74M Shares 8,891,758 Est. Cost $8.16 Unrealized —

AVIR ATEA PHARMACEUTICALS INC 1.8%

Value $22.22M Shares 2,485,638 Est. Cost $32.23 Unrealized -51.7%

TNGX TANGO THERAPEUTICS INC 1.7%

Value $21.02M Shares 1,921,790 Est. Cost $11.99 Unrealized +0.3%

— SYROS PHARMACEUTICALS INC 1.6%

Value $20.42M Shares 6,264,420 Est. Cost $10.27 Unrealized —

— MARINUS PHARMACEUTICALS INC 1.3%

Value $17M Shares 1,431,058 Est. Cost $15.48 Unrealized —

SVRA SAVARA INC 1.1%

Value $14.41M Shares 11,622,598 Est. Cost $1.49 Unrealized -20.0%

IVVD ADAGIO THERAPEUTICS INC 1.1%

Value $14.06M Shares 1,937,207 Est. Cost $37.11 Unrealized -29.9%

— SOLID BIOSCIENCES INC 1.1%

Value $13.88M Shares 7,929,918 Est. Cost $7.99 Unrealized —

— AEGLEA BIOTHERAPEUTICS INC 1.1%

Value $13.53M Shares 2,847,689 Est. Cost $9.18 Unrealized —

NAUT NAUTILUS BIOTECHNOLOGY INC 0.8%

Value $10.36M Shares 2,000,000 Est. Cost $10.83 Unrealized -50.6%

— RESEARCH ALLIANCE CORP II 0.8%

Value $9.77M Shares 1,000,000 Est. Cost $10.25 Unrealized —

— ARYA SCIENCES ACQU CORP IV 0.6%

Value $6.941M Shares 700,000 Est. Cost $10.47 Unrealized —

— X4 PHARMACEUTICALS INC 0.5%

Value $6.61M Shares 2,886,542 Est. Cost $8.12 Unrealized —

— BLUEBIRD BIO INC 0.4%

Value $5.376M Shares 538,179 Est. Cost $30.15 Unrealized —

— ARYA SCIENCES ACQUISITN CORP 0.4%

Value $4.85M Shares 500,000 Est. Cost $9.88 Unrealized —

— PANACEA ACQUISITION CORP II 0.4%

Value $4.85M Shares 500,000 Est. Cost $10.02 Unrealized —

— BCLS ACQUISITION CORP 0.4%

Value $4.778M Shares 487,500 Est. Cost $11.14 Unrealized —

— 2SEVENTY BIO INC 0.4%

Value $4.598M Shares 179,393 Est. Cost $25.63 Unrealized —

— OMEGA ALPHA SPAC 0.3%

Value $3.908M Shares 400,000 Est. Cost $9.90 Unrealized —

— FRAZIER LIFESCIENCES ACQU CO 0.2%

Value $2.976M Shares 300,000 Est. Cost $10.38 Unrealized —

— JIYA ACQUISITION CORP 0.2%

Value $2.931M Shares 300,000 Est. Cost $10.30 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	SPRINGWORKS THERAPEUTICS INC	4,831,307	$299M	23.7%	$21.68	—	COM	85205L107
—	DYNAVAX TECHNOLOGIES CORP	8,415,000	$118M	9.4%	$9.83	—	COM NEW	268158201
RPID	RAPID MICRO BIOSYSTEMS INC	8,434,560	$89.74M	7.1%	$20.66	-24.4%	CLASS A COM	75340L104
ARQT	ARCUTIS BIOTHERAPEUTICS INC	3,979,292	$82.53M	6.5%	$26.87	-25.9%	COM	03969K108
—	EQRX INC	10,003,573	$68.22M	5.4%	$6.82	—	COM	26886C107
NUVL	NUVALENT INC	3,428,014	$65.27M	5.2%	$29.01	-23.2%	COM	670703107
CRNX	CRINETICS PHARMACEUTICALS IN	2,029,701	$57.66M	4.6%	$18.52	+33.1%	COM	22663K107
CCCC	C4 THERAPEUTICS INC	1,642,210	$52.88M	4.2%	$29.00	+36.4%	COM STK	12529R107
PHVS	PHARVARIS N V	3,180,601	$45.77M	3.6%	$31.46	-50.3%	COM	N69605108
XLO	XILIO THERAPEUTICS INC	2,805,413	$44.89M	3.6%	$17.03	0.0%	COM	98422T100
ANNX	ANNEXON INC	3,241,628	$37.25M	3.0%	$23.46	-31.1%	COM	03589W102
NRIX	NURIX THERAPEUTICS INC	1,284,313	$37.18M	2.9%	$25.20	+20.3%	COM	67080M103
—	MERSANA THERAPEUTICS INC	5,385,667	$33.5M	2.7%	$17.67	—	COM	59045L106
—	APTINYX INC	8,891,758	$23.74M	1.9%	$8.16	—	COM	03836N103
AVIR	ATEA PHARMACEUTICALS INC	2,485,638	$22.22M	1.8%	$32.23	-51.7%	COM	04683R106
TNGX	TANGO THERAPEUTICS INC	1,921,790	$21.02M	1.7%	$11.99	+0.3%	COM	87583X109
—	SYROS PHARMACEUTICALS INC	6,264,420	$20.42M	1.6%	$10.27	—	COM	87184Q107
—	MARINUS PHARMACEUTICALS INC	1,431,058	$17M	1.3%	$15.48	—	COM NEW	56854Q200
SVRA	SAVARA INC	11,622,598	$14.41M	1.1%	$1.49	-20.0%	COM	805111101
IVVD	ADAGIO THERAPEUTICS INC	1,937,207	$14.06M	1.1%	$37.11	-29.9%	COM	00534A102
—	SOLID BIOSCIENCES INC	7,929,918	$13.88M	1.1%	$7.99	—	COM	83422E105
—	AEGLEA BIOTHERAPEUTICS INC	2,847,689	$13.53M	1.1%	$9.18	—	COM	00773J103
NAUT	NAUTILUS BIOTECHNOLOGY INC	2,000,000	$10.36M	0.8%	$10.83	-50.6%	COM	63909J108
—	RESEARCH ALLIANCE CORP II	1,000,000	$9.77M	0.8%	$10.25	—	COM CL A	760873109
—	ARYA SCIENCES ACQU CORP IV	700,000	$6.941M	0.6%	$10.47	—	CL A	G31659108
—	X4 PHARMACEUTICALS INC	2,886,542	$6.61M	0.5%	$8.12	—	COM	98420X103
—	BLUEBIRD BIO INC	538,179	$5.376M	0.4%	$30.15	—	COM	09609G100
—	ARYA SCIENCES ACQUISITN CORP	500,000	$4.85M	0.4%	$9.88	—	CLASS A ORD SHS	G31658100
—	PANACEA ACQUISITION CORP II	500,000	$4.85M	0.4%	$10.02	—	CL A SHS	G6882C106
—	BCLS ACQUISITION CORP	487,500	$4.778M	0.4%	$11.14	—	COM CL A	G0904B105
—	2SEVENTY BIO INC	179,393	$4.598M	0.4%	$25.63	—	COMMON STOCK	901384107
—	OMEGA ALPHA SPAC	400,000	$3.908M	0.3%	$9.90	—	CL A	G6749V107
—	FRAZIER LIFESCIENCES ACQU CO	300,000	$2.976M	0.2%	$10.38	—	UNIT 12/09/2025	G3710A121
—	JIYA ACQUISITION CORP	300,000	$2.931M	0.2%	$10.30	—	COM CL A	47760M102